Up-to-date, evidence-based oncology treatment regimens are made available in the Eviti Library.
Verified clinical trials to inform treatment decisions at the point of care.
Treatments You Can Trust
The Eviti Evidence-based Medical Library is composed of a variety of peer-reviewed sources. This includes published clinical trial data, oncology consensus group clinical practice guidelines, and research that has appeared in professional, peer-reviewed journals. These sources include (but are not limited to):
- The Journal of Clinical Oncology
- The Journal of the National Cancer Institute
- The Journal of the American Medical Association
- The Lancet Oncology Journal
- The New England Journal of Medicine
- American Society of Clinical Oncologists
- U.S. Food and Drug Administration
- National Comprehensive Cancer Network (NCCN) Compendium
- National Cancer Institute Physician Data Query (PDQ)
Minimum Requirements for Library Inclusion
Standards for inclusion in the Eviti Library include:
- The treatment must be recognized by one of the nationally/internationally recognized oncology consensus group organizations.
- Data from the supporting clinical trial must be available. For recommended or endorsed treatments that do not have diagnosis-specific clinical trial support, data may be extrapolated from closely-related clinical studies.
- Each individual drug within the regimen must be FDA approved for marketing in the United States, meaning the drugs are not experimental.
Driving High-Quality, High-Value Cancer Care
Confirm treatment efficacy
Regimens in the Eviti Library are verified and supported by research. Oncologists and payers can feel confident that patients are getting evidence-based care for their specific diagnosis.
Provide quality care
Quality comes from the ideal combination of treatment effectiveness and value. The Eviti Library covers all cancer types so all patients can receive the best possible care.
Access up-to-date information
After passing rigorous validation, treatments in the Eviti Library are updated in real-time, giving oncologists accurate and relevant information when they need it most.